top of page

Mechanism of Action Underlying Ketamine s Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

About the study

NCT Trial Number

NCT03973268

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

National Institute of Mental Health (NIMH)
National Institutes of Health Clinical Center (CC)

noun_date_3237048.png

Trial Start Date

Jan-20

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 70 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

​

​

Eyes Graffiti

Locations


United States, Maryland
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892

Contact:
Office of Patient Recruitment (OPR)
800-411-1222 ext TTY8664111010
prpl@cc.nih.gov

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page